Co-Altria: Co-Altria Tablets are contraindicated in patients with known hypersensitivity to montelukast, levocetirizine, to other piperazine derivatives or to any of the excipients. Also, contraindicated in patients with severe renal impairment at less than 10 ml/min creatinine clearance, and patients undergoing haemodialysis.
Co-Altria Ped: It is contraindicated in patients with known hypersensitivity to Montelukast, Levocetirizine, to other piperazine derivatives, or to any of the excipients. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. Also contraindicated in patients with severe renal impairment at less than 10 mL/min creatinine clearance.
Other Services
Country
Account